KPV
Contents
What is KPV?
KPV is a short peptide composed of three amino acids—lysine, proline, and valine. In fact, the letters making up the name are the chemical abbreviations of these amino acids (K=lysine, P=proline, V=valine). KPV has drawn interest for its potent anti-inflammatory properties. It is derived from a larger naturally occurring hormone called alpha-melanocyte–stimulating hormone (α-MSH). The KPV portion of α-MSH plays a role in immune regulation and inflammation control. Researchers discovered that KPV retains much of α-MSH’s anti-inflammatory activity without affecting pigmentation or hormonal balance.
What is α-MSH?
Alpha-MSH is a peptide hormone produced in the pituitary gland and other tissues. It helps regulate inflammation, immune responses, and skin pigmentation. While α-MSH has broad effects in the body, its use as a therapy is limited because it also influences melanocytes (leading to tanning) and other hormonal pathways. KPV isolates the anti-inflammatory portion of α-MSH while avoiding these unwanted effects. See our articles on Melanotan I and Melanotan II for more information of the tanning effects of α-MSH.
How Does KPV Work?
KPV works primarily by modulating immune signaling pathways involved in inflammation. One of its key actions is inhibition of NF-κB, a transcription factor that controls the production of many inflammatory cytokines such as TNF-α, IL-1β, and IL-6. By dampening this pathway, KPV reduces excessive inflammatory signaling at the cellular level.
KPV has also been shown to stabilize epithelial barriers, particularly in the gut. This helps protect tissues from inflammatory damage and supports healing. Unlike traditional anti-inflammatory drugs, KPV does not broadly suppress the immune system; instead, it helps restore balance to an overactive inflammatory response.
What is KPV Used for?
Researchers are studying the role of KPV in the following applications:
- Inflammatory bowel conditions such as ulcerative colitis
- Skin conditions like eczema, psoriasis, and inflammatory acne
- Autoimmune and chronic inflammatory disorders
- Support for wound healing in inflamed tissues
KPV Side Effects
KPV has demonstrated a strong safety profile in experimental studies, with minimal toxicity observed. Because it does not affect pigmentation or major hormonal systems, side effects appear limited. Human clinical data is still emerging, and long-term effects have not yet been fully characterized.
KPV Dosing Protocol (for Research)
While recommended dosages have not been established, extrapolating from the animal studies, the following research algorithm is recommended (injection under the skin, i.e. subcutaneous):
- 1Weeks 1-2: 100 µg (0.1 mg) daily
- 2Weeks 3-4: 200 µg (0.2 mg)daily
- 3Week 5-6: 400 µg (0.4 mg) daily
- 4Week 7 and beyond: 500 µg (0.5 mg) daily
Recommended KPV Source (for Research)
